Glycome Atlas
Process
Also known as non-enzymatic glycation, Maillard reaction
Plain-language answer
Glycation is what happens when sugar in the blood sticks to proteins on its own, without any enzyme helping it along. A sugar molecule latches onto a protein, and over time that loose attachment matures into a permanent, browned modification. It is the same basic chemistry that turns toast golden, only it is happening slowly inside the body.12
The higher and more sustained blood sugar is, the more glycation builds up on long-lived proteins in blood vessels, nerves, and the lens of the eye. This gradual sugar coating stiffens and damages tissues and is one of the mechanisms that links diabetes and high blood sugar to complications in the heart, kidneys, eyes, and nerves.1
Technical detail
Glycation is the non-enzymatic covalent attachment of reducing sugars or reactive carbonyl species to free amino groups of proteins, lipids, and nucleic acids, proceeding through reversible Schiff base and Amadori intermediates before maturing via the Maillard reaction into stable advanced glycation end products.1
The initial step is nucleophilic addition of a protein amino group, typically the epsilon-amino group of lysine or the guanidino group of arginine, to the open-chain carbonyl of a reducing sugar, forming a labile Schiff base. Intramolecular rearrangement yields the Amadori product, a comparatively stable ketoamine. Subsequent oxidation, dehydration, fragmentation, and cross-linking reactions, collectively the advanced stages of the Maillard reaction, generate a chemically diverse family of advanced glycation end products.1
Highly reactive dicarbonyl intermediates such as methylglyoxal and glyoxal accelerate the process, reacting with arginine and lysine residues far faster than glucose itself and acting as major precursors of advanced glycation end products.1
Glycation must not be conflated with glycosylation. Glycosylation is an enzyme-directed, template-independent but tightly regulated biosynthetic process that attaches defined glycan structures at specific sites. Glycation is spontaneous, uncatalyzed, and driven by substrate concentration and time, so it produces heterogeneous, non-programmed adducts whose accumulation reflects metabolic exposure rather than biological design.12
Human relevance
Chronic hyperglycemia increases glycation of long-lived proteins, and the resulting advanced glycation end products are mechanistically implicated in the microvascular and macrovascular complications of diabetes.1
Continue exploring
References